June 24, 2024 · Form 4 insider transaction
Bassler Bonnie L sold 756 shares of Regeneron Pharmaceuticals, Inc. at $1062.00 per share, a transaction worth $802.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 27, 2024.